Fitzgibbon Dermot R
Department of Anesthesiology, University of Washington School of Medicine, Seattle, WA 98195, USA.
Curr Pain Headache Rep. 2007 Aug;11(4):251-8. doi: 10.1007/s11916-007-0200-x.
Successful management of pain in the cancer patient requires careful assessment of the components of the pain complaint and accurate diagnosis of the cause of pain. Symptomatic management of pain involves pharmacotherapeutic strategies that focus on opioid use. Factors influencing the choice of opioid in patients with cancer pain include the severity of pain, the presence of coexisting disease, response to previous analgesic therapy, pharmacokinetic factors, available formulations, and patient compliance. Long-term opioid prescription always requires individual titration of medication to adequate pain relief, which is determined on an individual patient basis and/or based on manageable adverse effects. Failure to continuously monitor opioid use generally results in overtreatment or undertreatment of pain. The cognitive and psychomotor effects of long-term opioid therapy are not well-defined and merit further study.
成功管理癌症患者的疼痛需要仔细评估疼痛主诉的各个组成部分,并准确诊断疼痛原因。疼痛的对症治疗涉及以使用阿片类药物为重点的药物治疗策略。影响癌症疼痛患者阿片类药物选择的因素包括疼痛的严重程度、并存疾病的存在、对先前镇痛治疗的反应、药代动力学因素、可用剂型以及患者的依从性。长期阿片类药物处方始终需要根据个体情况调整药物剂量以实现充分的疼痛缓解,这要根据个体患者的情况和/或基于可控制的不良反应来确定。未能持续监测阿片类药物的使用通常会导致疼痛治疗过度或不足。长期阿片类药物治疗的认知和精神运动效应尚不明确,值得进一步研究。